List of works by Ronnie Shapira-Frommer

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors

scientific article published on 6 March 2017

A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study

scientific article published on 29 July 2013

Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?

scientific article

Adoptive immunotherapy of advanced melanoma

scientific article published on September 2012

Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies

scientific article

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.

scientific article published on 4 September 2017

Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety

scientific article published on 01 November 2019

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study

scientific article published in February 2008

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

scientific article published on 10 September 2020

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

scientific article published on 10 April 2017

CT halo sign as an imaging marker for response to adoptive cell therapy in metastatic melanoma with pulmonary metastases

scientific article published on 26 March 2014

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients

scientific article

Clinical significance of pancreatic atrophy induced by immune checkpoint inhibitors: A case-control study

scientific article published on 01 October 2018

Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response

scientific article published on 06 April 2020

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.

scientific article published on 22 February 2018

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

scientific article published on 03 April 2019

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study

scientific article published on 24 January 2020

Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial

scientific article published on 09 January 2019

Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

scientific article published on 23 December 2015

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

scientific article published on 04 November 2019

Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study

scientific article published on 06 August 2013

Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy

scientific article published on March 2011

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

scientific article published on 10 December 2020

Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients

scientific article published on 14 January 2019

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

scientific article published on 24 October 2018

Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients

scientific article

Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma

scientific article

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

scientific article published on 27 March 2012

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

scientific article

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.

scientific article published on 08 April 2016

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation

scientific article published on 03 November 2014

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.

scientific article published on 08 September 2016

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer ⬇️

journal article from 'New England Journal of Medicine' published in 2021

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

scientific article

Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanoma

scientific article published on 07 August 2018

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.

scientific article published on 8 November 2016

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma

scientific article published on 18 August 2020

Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors

scientific article published on 18 February 2019

Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors

scientific article published on 13 January 2018

TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma

scientific article published on 09 September 2019

Tumor lysis syndrome and malignant melanoma.

scientific article published on 15 May 2013

Tumor-Infiltrating Lymphocytes: Clinical Experience

scientific article

Paulina is supported by:

About Paulina

Help